I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Table_1_Commentary: Cost-Effectiveness Analysis of Rivaroxa..:
Shalin Rawal
;
Kamal Sharma
;
Aditya Shah
...
doi:10.3389/fcvm.2022.916705.s001. , 2022
Link:
https://doi.org/10.3389/fcvm.2022.916705.s001
RT Journal T1
Table_1_Commentary: Cost-Effectiveness Analysis of Rivaroxaban Plus Aspirin Compared With Aspirin Alone in Patients With Coronary and Peripheral Artery Diseases in Italy.pdf
UL https://suche.suub.uni-bremen.de/peid=base-ftfrontimediafig:oai:figshare.com:article_20129810&Exemplar=1&LAN=DE A1 Shalin Rawal A1 Kamal Sharma A1 Aditya Shah A1 Shriya Bavishi A1 Cleris Christian A1 Parjanya Bhatt A1 Ashwati Konat YR 2022 K1 Cardiology K1 Cardiology (incl. Cardiovascular Diseases) K1 Cardiorespiratory Medicine and Haematology not elsewhere classified K1 cost-effectiveness K1 rivaroxaban K1 dual pathway inhibitor K1 incremental cost-effectiveness ratio (ICER) K1 Quality-Adjusted Life-Years (QALY) JF doi:10.3389/fcvm.2022.916705.s001 LK http://dx.doi.org/https://doi.org/10.3389/fcvm.2022.916705.s001 DO https://doi.org/10.3389/fcvm.2022.916705.s001 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)